-
1 Comment
Syncona Limited is currently in a long term downtrend where the price is trading 11.7% below its 200 day moving average.
From a valuation standpoint, the stock is 66.2% cheaper than other stocks from the Financial Services sector with a price to sales ratio of 17.9.
Finally, its free cash flow fell by 153.9% to $-8M since the same quarter in the previous year.
Based on the above factors, Syncona Limited gets an overall score of 1/5.
Exchange | LSE |
---|---|
ISIN | GG00B8P59C08 |
Sector | Financial Services |
Industry | Asset Management |
CurrencyCode | GBP |
Beta | 0.25 |
---|---|
Market Cap | 543M |
PE Ratio | None |
Target Price | 225 |
Dividend Yield | None |
Syncona Limited is a fund specializes in investments in hedge, equity and long-term alternative investment funds across multiple asset classes. It manages private equity, debt, fixed income and alternative investments. The fund prefers to invest in healthcare and life sciences sector with focus on Cell therapy, gene therapy, biologics and small molecules. The fund invests in the public equity and fixed income markets across the globe. It targets attractive medium to long term returns by investing in leading long-only and alternative investment funds with proven managers and across multiple asset classes. The firm invests in separately managed account portfolios.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for SYNC.LSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025